The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?

References

• Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. Am J Med 1952;13:583–90.
   PubMed Web of Science ®Google Scholar
• Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773–8.
   PubMed Web of Science ®Google Scholar
• Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818–26.
   PubMed Web of Science ®Google Scholar
• Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008;14:968–76.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Jess T, Bodin L, Jarnerot G, Munkholm P, Binder V, Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1536–44.
   PubMedGoogle Scholar
• Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev Mol Diagn 2006;6:345–63.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767–73.
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aksentijevich I. The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2002;2:511–16.
   PubMed Web of Science ®Google Scholar
• McGonagle D, Aziz A, Dickie LJ, McDermott MF. An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum. Pediatr Res 2009;65:38R–45R.
   Google Scholar
• Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 2007;147:227–35.
   PubMed Web of Science ®Google Scholar
• Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 2005;7:427–33.
   PubMedGoogle Scholar
• Bolton PM, James SL, Hughes LE. Is there impaired immunity in patients with Crohn's disease? Br J Surg 1973;60:319.
   PubMedGoogle Scholar
• Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976;2:219–21.
   PubMed Web of Science ®Google Scholar
• Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995;84:1386–94.
   PubMed Web of Science ®Google Scholar
• Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin Gastroenterol Hepatol 2004;2:690–5.
   PubMedGoogle Scholar
• Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol 2009;104:117–24.
   PubMed Web of Science ®Google Scholar
• Couper R, Kapelushnik J, Griffiths AM. Neutrophil dysfunction in glycogen storage disease Ib: association with Crohn's-like colitis. Gastroenterology 1991;100:549–54.
   PubMedGoogle Scholar
• Garty BZ, Douglas SD, Danon YL. Immune deficiency in glycogen storage disease type 1B. Isr J Med Sci 1996;32:1276–81.
   PubMedGoogle Scholar
• Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis 2009;16:703–11.
   Google Scholar
• Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006;367:668–78.
   PubMed Web of Science ®Google Scholar
• Granzotto M, Fabbro E, Maschio M, Martelossi S, Quaglia S, Tommasini A, Presani G, Ventura A. Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn's disease. World J Gastroenterol 2007;13:6191–6.
   PubMedGoogle Scholar
• Palmer CD, Rahman FZ, Sewell GW, Ahmed A, Ashcroft M, Bloom SL, Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease. PloS One 2009;4:e7787.
   Google Scholar
• Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009;206:1883–97.
   PubMed Web of Science ®Google Scholar
• Glasser AL, Darfeuille-Michaud A. Abnormalities in the handling of intracellular bacteria in Crohn's disease: a link between infectious etiology and host genetic susceptibility. Arch Immunol Ther Exp 2008;56:237–44.
   PubMedGoogle Scholar
• Balaci L, Spada MC, Olla N, Sole G, Loddo L, Anedda F, IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 2007;80:1103–14.
   PubMed Web of Science ®Google Scholar
• Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP, Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Investig Dermatol 2007;127:564–7.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18–20.
   PubMed Web of Science ®Google Scholar
• Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005;105:1195–7.
   PubMed Web of Science ®Google Scholar
• Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033–45.
   PubMed Web of Science ®Google Scholar
• Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, Ventura A. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr 2009;168:149–55.
   PubMed Web of Science ®Google Scholar
• Liu S, Abrams D, Baldassano RN, Sullivan KE. Prevalence of chronic granulomatous disease in pediatric patients diagnosed with Crohn's disease. Inflamm Bowel Dis 2008;14:727–8.
   PubMedGoogle Scholar
• Schappi MG, Smith VV, Goldblatt D, Lindley KJ, Milla PJ. Colitis in chronic granulomatous disease. Arch Dis Child 2001;84:147–51.
   PubMed Web of Science ®Google Scholar
• Isaacs D, Wright VM, Shaw DG, Raafat F, Walker-Smith JA. Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr 1985;4:498–501.
   PubMed Web of Science ®Google Scholar
• Yogman MW, Touloukian RJ, Gallagher R. Letter: intestinal granulomatosis in chronic granulomatous disease and in Crohn's disease. N Engl J Med 1974;290:228.
   PubMedGoogle Scholar
• Huang J, Liao C, Wu L, Cao Y, Gao F. A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn's disease. Colorectal Dis 2009; Epub ahead of print.
   Google Scholar
• Freudenberg F, Wintergerst U, Roesen-Wolff A, Albert MH, Prell C, Strahm B, Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. J Allergy Clin Immunol 2010;125:943–6.el.
   PubMed Web of Science ®Google Scholar
• Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 2007;204:381–91.
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Maillard MH, Cotta-de-Almeida V, Mizoguchi E, Klein C, Fuss I, Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Gastroenterology 2007;133:1188–97.
   PubMedGoogle Scholar
• Visser G, Rake JP, Kokke FT, Nikkels PG, Sauer PJ, Smit GP. Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 2002;25:261–7.
   PubMedGoogle Scholar
• Lamport RD, Katz S, Eskreis D. Crohn's disease associated with cyclic neutropenia. Am J Gastroenterology 1992;87:1638–42.
   PubMedGoogle Scholar
• D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E. Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 1996;39:605–8.
   PubMedGoogle Scholar
• Vannier JP, Arnaud-Battandier F, Ricour C, Schmitz J, Buriot D, Griscelli C, Rey J. Chronic neutropenia and Crohn's disease in childhood. Report of 2 cases. Arch Franc Pediatr 1982;39:367–70.
   PubMedGoogle Scholar
• Stevens C, Peppercorn MA, Grand RJ. Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 1991;13:328–30.
   PubMedGoogle Scholar
• Hoover EG, DuBois JJ, Samples TL, McCullough JS, Chenaille PJ, Montes RG. Treatment of chronic enteritis in glycogen storage disease type IB with granulocyte colony-stimulating factor. J Pediatr Gastroenterol Nutr 1996;22:346–50.
   PubMedGoogle Scholar
• Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992;326:1666–9.
   PubMed Web of Science ®Google Scholar
• Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998;42:127–30.
   PubMed Web of Science ®Google Scholar
• Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS. Cyclic neutropenia in Crohn's ileocolitis: efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 1997;24:253–6.
   PubMedGoogle Scholar
• Wilk JN, Viney JL. GM-CSF treatment for Crohn's disease: a stimulating new therapy? Curr Opin Investig Drugs 2002;3:1291–6.
   PubMedGoogle Scholar
• Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002;360:1478–80.
   PubMed Web of Science ®Google Scholar
• Moss AC, Farrell RJ. Adding fuel to the fire: GM-CSF for active Crohn's disease. Gastroenterology 2005;129:2115–17.
   PubMedGoogle Scholar
• Bernasconi E, Favre L, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflamm Bowel Dis 2010;16:428–41.
   PubMedGoogle Scholar
• Rajakariar R, Newson J, Jackson EK, Sawmynaden P, Smith A, Rahman F, Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate. J Immunol 2009;182:3262–9.
   PubMedGoogle Scholar
• Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955–62.
   PubMed Web of Science ®Google Scholar
• Press RD. Crohn's disease is caused by mutations in the bacterial response protein NOD2. Mol Diagn 2001;6:347–8.
   Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nat 2001;411:603–6.
   Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nat 2001;411:599–603.
   Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731–4.
   PubMed Web of Science ®Google Scholar
• Noguchi E, Homma Y, Kang X, Netea MG, Ma X. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 2009;10:4719.
   Google Scholar
• Yamamoto-Furusho JK, Barnich N, Hisamatsu T, Podolsky DK. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function. Inflamm Bowel Dis 2010;16:736–42.
   PubMedGoogle Scholar
• Barreau F, Madre C, Dusaillant M, Berrebi D, Merlin F, Sterkers G, Nod2 regulates the host response towards microflora by modulating T-cell function and epithelial permeability in mouse Peyer's patches. Gut: 2009.
   PubMedGoogle Scholar
• Canto E, Moga E, Ricart E, Garcia-Bosch O, Garcia-Planella E, Juarez C, Vidal S. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients. Inflamm Bowel Dis 2009;15:1686–96.
   PubMedGoogle Scholar
• Zhang HF, Qiu LX, Chen Y, Zhu WL, Mao C, Zhu LG, ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet 2009;125:627–31.
   PubMedGoogle Scholar
• Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 2007;132:1665–71.
   PubMed Web of Science ®Google Scholar
• Folwaczny C, Glas J, Torok HP. Crohn's disease: an immunodeficiency? Eur J Gastroenterol Hepatol 2003;15:621–6.
   PubMedGoogle Scholar
• Casanova JL, Abel L. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 2009;206:1839–43.
   PubMedGoogle Scholar
• Cadwell K, Stappenbeck TS, Virgin HW. Role of autophagy and autophagy genes in inflammatory bowel disease. Curr Top Microbiol Immunol 2009;335:141–67.
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010;11:55–62.
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010;16:90–7.
   PubMed Web of Science ®Google Scholar
• Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol 2009;10:461–70.
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Huett A, Rioux JD. Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis. Gut 2008;57:717–20.
   PubMedGoogle Scholar
• Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protocols 2007;2:541–6.
   PubMed Web of Science ®Google Scholar
• Wirtz S, Neurath MF. Gene transfer approaches for the treatment of inflammatory bowel disease. Gene Ther 2003;10:854–60.
   PubMed Web of Science ®Google Scholar
• Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005;58:568–72.
   PubMed Web of Science ®Google Scholar
• Lewis K, Lutgendorff F, Phan V, Soderholm JD, Sherman PM, McKay DM. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 2009; Epub ahead of print.
   Google Scholar
• Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009;27:443–9.
   PubMed Web of Science ®Google Scholar
• Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005;62:1297–307.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2005;77:460–5.
   PubMed Web of Science ®Google Scholar
• Keita AV, Salim SY, Jiang T, Yang PC, Franzen L, Soderkvist P, Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J Pathol 2008;215:135–44.
   PubMed Web of Science ®Google Scholar
• Ma TY. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997;214:318–27.
   PubMed Web of Science ®Google Scholar
• Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, Morelli L. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN 2005;29:S173–5, discussion S5–8, S84–8.
   PubMed Web of Science ®Google Scholar
• Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998;14:345–50.
   PubMed Web of Science ®Google Scholar
• Sewell GW, Marks DJ, Segal AW. The immunopathogenesis of Crohn's disease: a three-stage model. Curr Opin Immunol 2009;21:506–13.
   PubMed Web of Science ®Google Scholar
• Salh B, Hoeflick K, Kwan W, Pelech S. Granulocyte-macrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C. Immunology 1998;95:473–9.
   PubMedGoogle Scholar
• Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: moving toward a stem cell-based therapy. World J Gastroenterol 2008;14:4616–26.
   PubMed Web of Science ®Google Scholar
• Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008;57:211–17.
   PubMed Web of Science ®Google Scholar